Binding of thrombin to thrombomodulin results in loss of thrombin’s procoagulant and profibrogenic properties and acquisition of the ability to activate protein C. It has thus been hypothesised that a reduction in thrombomodulin levels in MM may confer a hypercoagulable profile in patients. Here, THBD is linked to Miyoshi myopathy.